Eastwood Bio-Medical Canada Statistics
Want to see TSE:EBM full AI Analyst Report?
Eastwood Bio-Medical Canada (EBM) Stock Statistics & Valuation Metrics
Total Valuation
Eastwood Bio-Medical Canada has a market cap or net worth of CAD 113.66M. The enterprise value is CAD 66.88M.
- Market Cap
- CAD 113.66M
- Enterprise Value
- CAD 66.88M
Share Statistics
Eastwood Bio-Medical Canada has 68,885,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 68,885,970
- Owned by Insiders
- 69.11%
- Owned by Institutions
- ―
Financial Efficiency
Eastwood Bio-Medical Canada’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 22.86%.
- Return on Equity (ROE)
- 0.20
- Return on Assets (ROA)
- -1.52
- Return on Invested Capital (ROIC)
- 22.86%
- Return on Capital Employed (ROCE)
- 0.22
- Revenue Per Employee
- 260.69K
- Profits Per Employee
- -110.92K
- Employee Count
- 3
- Asset Turnover
- 3.57
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Eastwood Bio-Medical Canada is -532.26. Eastwood Bio-Medical Canada’s PEG ratio is -8.24.
- PE Ratio
- -532.26
- PS Ratio
- 139.96
- PB Ratio
- -63.71
- Price to FCF
- -12066.01
- Price to Operating Cash Flow
- -12055.78
- PEG Ratio
- -8.24
Income Statement
In the last 12 months, Eastwood Bio-Medical Canada had revenue of 782.08K and earned -332.77K in profits. Earnings per share was -0.00.
- Revenue
- 782.08K
- Gross Profit
- 506.03K
- Operating Income
- -354.70K
- Pretax Income
- -332.77K
- Net Income
- -332.77K
- EBITDA
- -309.73K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -9,428 and capital expenditures 8, giving a free cash flow of -9,420 billion.
- Operating Cash Flow
- -9,428
- Free Cash Flow
- -9,420
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Eastwood Bio-Medical Canada pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- >-0.01%
- Earnings Yield
- -0.20%
Stock Price Statistics
- Beta
- 0.41
- 52-Week Price Change
- 50.00%
- 50-Day Moving Average
- 1.87
- 200-Day Moving Average
- 1.15
- Relative Strength Index (RSI)
- 37.98
- Average Volume (3m)
- 8,649
Important Dates
Eastwood Bio-Medical Canada upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 29, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Eastwood Bio-Medical Canada as a current ratio of 0.02, with Debt / Equity ratio of -4.79%
- Current Ratio
- 0.02
- Quick Ratio
- 0.02
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.19
- Interest Coverage Ratio
- -39.38
Taxes
In the past 12 months, Eastwood Bio-Medical Canada has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Eastwood Bio-Medical Canada EV to EBITDA ratio is -476.63, with an EV/FCF ratio of -12072.40.
- EV to Sales
- 140.03
- EV to EBITDA
- -476.63
- EV to Free Cash Flow
- -12072.40
- EV to Operating Cash Flow
- -12062.15
Balance Sheet
Eastwood Bio-Medical Canada has CAD 3,528.00 in cash and marketable securities with CAD 63.65K in debt, giving a net cash position of -CAD 60.12K billion.
- Cash & Marketable Securities
- CAD 3,528.00
- Total Debt
- CAD 63.65K
- Net Cash
- -CAD 60.12K
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- -CAD 0.03
Margins
Gross margin is 66.27%, with operating margin of -33.24%, and net profit margin of -28.51%.
- Gross Margin
- 66.27%
- Operating Margin
- -33.24%
- Pretax Margin
- -28.51%
- Net Profit Margin
- -28.51%
- EBITDA Margin
- -29.38%
- EBIT Margin
- -33.24%
Analyst Forecast
The average price target for Eastwood Bio-Medical Canada is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 36.59%
- EPS Growth Forecast
- 43.33%
Scores
- Smart Score
- ―
- AI Score
- 47
